Skip to main content
Jasmine Francis, MD, Ophthalmology, New York, NY

Jasmine H Francis MD

Retinal Disease, Ocular Oncology


Physician

Request appointment
  • 160 East 53rd StreetNew York, NY 10022

  • Book by Phone+1(419) 854-2447

Overview of  Dr. Francis

Dr. Jasmine Francis is an ophthalmologist in New York, NY and is affiliated with Memorial Sloan Kettering Cancer Center. She received her medical degree from New York University School of Medicine and has been in practice 19 years. She is one of 26 doctors at Memorial Sloan Kettering Cancer Center who specialize in Ophthalmology. She has more than 100 publications and over 500 citings.

Education & Training

  • Icahn School of Medicine at Mount Sinai/New York Eye and Ear Infirmary at Mount Sinai
    Icahn School of Medicine at Mount Sinai/New York Eye and Ear Infirmary at Mount SinaiResidency, Ophthalmology, 2008 - 2011
  • New York University School of Medicine
    New York University School of MedicineClass of 2007

Certifications & Licensure

  • NY State Medical License
    NY State Medical License 2008 - 2028
  • Ophthalmology
    American Board of Ophthalmology Ophthalmology

Publications & Presentations

PubMed

Journal Articles

  • Ten-Year Experience with Ophthalmic Artery Chemosurgery: Ocular and Recurrence-Free Survival  
    David H Abramson, Y Pierre Gobin, Jasmine H Francis, PLOS ONE
  • Growth Patterns of Survivors of Retinoblastoma Treated with Ophthalmic Artery Chemosurgery  
    Jasmine H Francis, Y Pierre Gobin, David H Abramson, PLoS One
  • Total Retinal Detachments Due to Retinoblastoma: Outcomes Following Intra-Arterial chemotherapy/ophthalmic Artery Chemosurgery  
    Ira J Dunkel, Jasmine H Francis, Y Pierre Gobin, Scott E Brodie, David H Abramson, PLoS One

Press Mentions

  • Hearing Evaluations in Children with Retinoblastoma Treated with Intra-Arterial Carboplatin Chemotherapy: A Single Institution Review
    Hearing Evaluations in Children with Retinoblastoma Treated with Intra-Arterial Carboplatin Chemotherapy: A Single Institution ReviewSeptember 10th, 2024
  • FDA Approves First Treatment for Patients with All Forms of Histiocytosis
    FDA Approves First Treatment for Patients with All Forms of HistiocytosisJanuary 30th, 2023
  • Doctors Identify an Eye Cancer Culprit
    Doctors Identify an Eye Cancer CulpritSeptember 13th, 2021

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: